SecBot SecBot
8-K ·Filed Sep 14, 2026

AIM

AIM ImmunoTech Inc.
BEARISH
Impact 7/10
Horizondays Processed1mo ago SEC0001493152-26-042592
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

The immediate tradability of these shares under Rule 144 creates heavy selling pressure risk for a micro-cap with thin liquidity. Monitor for Streeterville Capital selling into the market — any volume spikes likely represent distribution. The remaining ~$2.9M of the original note could be converted similarly, adding further overhang.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+5d
AIM ▲ 0.00% at T+5d
SHORT call ✗ call lost 0.00% · α vs SPY +0.82% · entry $0.2100 → $0.2100
Next anchor: T+20d due 14d ago
Entry anchored
Sep 14, 04:35 PM ET
via 1-min bar
T+1d
+0.76%
call -0.76% · α -0.44%
$0.2116
settled 6w ago
T+5d
0.00%
call 0.00% · α +0.82%
$0.2100
settled 5w ago
T+20d
Pending
due 14d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

AIM ImmunoTech converted approximately $400,000 of its existing promissory note with Streeterville Capital into 1,749,434 common shares at ~$0.228/share, reducing debt but adding ~$8M market cap worth of new shares to a sub-$8M market cap company. The shares are issued without restrictive legend under Section 3(a)(9), meaning immediate resale potential, which creates significant overhang for a micro-cap stock.

Key Financial Metrics

Offering Size
$400.0K

Key Facts

  • Converted ~$400,000 of promissory note into 1,749,434 common shares at ~$0.228 per share
  • Shares issued free of restrictive legend under Section 3(a)(9) — immediately tradable
  • Original note was $3,301,250 from November 2025; remaining balance reduced by $400,000
  • Stockholders approved conversion at July 15, 2026 special meeting
  • Market cap is ~$8M — new shares represent ~22% dilution based on conversion price vs market

Financial Impact

~$400,000 debt reduction exchanged for 1,749,434 shares at ~$0.228/share; shares are immediately tradable, creating significant overhang for an $8M market cap company

dilutiondebtshare count

Risk Factors

  • Immediate share overhang from 1.75M freely tradable shares relative to ~$8M market cap
  • Remaining ~$2.9M of original note could be converted similarly, adding more dilution
  • Streeterville Capital is a known distressed lender — likely to sell shares quickly

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-042592
Exhibit: ex10-1.htm0001493152-26-042592
Document: 0001493152-26-042592-index-headers.html0001493152-26-042592
Document: 0001493152-26-042592-index.html0001493152-26-042592
Document: 0001493152-26-042592.txt0001493152-26-042592
31 reports for AIM
Performance horizon
63% Hit rate @ T+20 10 of 16 directional calls Went positive at some point 14 of 18 best @ T+20▲ +57.69%May 14, 2026
Filters
Rows
Reports for AIM — sortable, filterable
TypeNow
Sep 30, 2026
25d ago
DEF 14A
NEUTRAL ★ 3/10
$0.1877awaiting T+20—$0.1600 (−14.76%)
Sep 22, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$0.2156 $0.1662▼ −22.91%▼ −22.35%$0.1600 (−25.79%)
Sep 14, 2026
5w ago
8-K
BEARISH ★ 7/10
$0.2100awaiting T+20—$0.1600 (+23.81%)
Aug 11, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$0.2500 $0.2332▼ −6.72%▼ −5.66%$0.1600 (−36.00%)
Aug 10, 2026
10w ago
8-K
BEARISH ★ 5/10
$0.2630awaiting T+20—$0.1600 (+39.16%)
Aug 10, 2026
10w ago
Press Release
BEARISH ★ 5/10
$0.2630awaiting T+20—$0.1600 (+39.16%)
Aug 5, 2026
11w ago
8-K
MIXED ★ 6/10
$0.2800 $0.2346▼ −16.21%▼ −15.61%$0.1600 (−42.86%)
Aug 3, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$0.2600 $0.2260▼ −13.08%▼ −14.31%$0.1600 (−38.46%)
Jun 24, 2026
17w ago
EFFECT
BEARISH ★ 7/10
$0.3740 $0.2534▲ +32.25%▲ +34.18%$0.1600 (+57.22%)
Jun 18, 2026
18w ago
S-1
BEARISH ★ 7/10
$0.3799 $0.2730▲ +28.14%▲ +28.67%$0.1600 (+57.88%)
Showing 10 of 31

US Market Status

Market Closed — Opens in 1h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers